Jin LI
Academic / Other · 2 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Single-arm, Multicenter, Phase II Clinical Study of Camrelizumab Combined With Famitinib in Adjuvant Therapy Cervical Cancer, Radical Surgery, Adjuvant Therapy | N/A | 2026-04-01 |
| Not Yet Recruiting | Fluzoparib Combined With Apatinib in Relapsed Ovarian Carcinoma Maintenance Treatment Relapsed Ovarian Cancer | Phase 2 | 2023-10-30 |